Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Measurement of High Blood Pressure Using Boppli

NCT: NCT07547917 · NOT_YET_RECRUITING

NCT IDNCT07547917
StatusNOT_YET_RECRUITING
Start Date2026-04-13
Completion2031-06-01

Brief Summary

This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants. The study compares Boppli measurements to standard blood pressure cuff measurements to determine how well the device works and whether it improves identification of high blood pressure in infants in the neonatal intensive care unit (NICU). The study also includes follow-up through 1 year of age to understand longer-term outcomes.

Frequently Asked Questions

What is Measurement of High Blood Pressure Using Boppli?

Measurement of High Blood Pressure Using Boppli is a clinical trial registered under NCT07547917. Current status: NOT_YET_RECRUITING.

What is the status of NCT07547917?

The current status of NCT07547917 (Measurement of High Blood Pressure Using Boppli) is: NOT_YET_RECRUITING.

When did Measurement of High Blood Pressure Using Boppli start?

Measurement of High Blood Pressure Using Boppli started on 2026-04-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.